Novartis Investigative Site

Winter Haven, Florida 33881

0 studies enrolling now · 7 studies all time

What they study most

Acute Heart Failure, Age-related Macular Degeneration, Diabetic Macular Edema, Geographic Atrophy, Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusions

Studies at this site

• Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema — Completed
• Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. — Completed
• Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) — Completed
• Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD — Completed
• Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD). — Stopped early
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed